These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23564714)

  • 1. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.
    Ryan ER; Sofocleous CT; Schöder H; Carrasquillo JA; Nehmeh S; Larson SM; Thornton R; Siegelbaum RH; Erinjeri JP; Solomon SB
    Radiology; 2013 Jul; 268(1):288-95. PubMed ID: 23564714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
    Sainani NI; Shyn PB; Tatli S; Morrison PR; Tuncali K; Silverman SG
    J Vasc Interv Radiol; 2011 Mar; 22(3):354-60. PubMed ID: 21353987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation.
    Venkatesan AM; Kadoury S; Abi-Jaoudeh N; Levy EB; Maass-Moreno R; Krücker J; Dalal S; Xu S; Glossop N; Wood BJ
    Radiology; 2011 Sep; 260(3):848-56. PubMed ID: 21734159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immediate Postablation
    Cornelis FH; Petre EN; Vakiani E; Klimstra D; Durack JC; Gonen M; Osborne J; Solomon SB; Sofocleous CT
    J Nucl Med; 2018 Sep; 59(9):1360-1365. PubMed ID: 29439012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
    Shyn PB; Casadaban LC; Sainani NI; Sadow CA; Bunch PM; Levesque VM; Kim CK; Gerbaudo VH; Silverman SG
    Radiology; 2018 Jul; 288(1):138-145. PubMed ID: 29613843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT for the prediction and detection of local recurrence after radiofrequency ablation of malignant lung lesions.
    Singnurkar A; Solomon SB; Gönen M; Larson SM; Schöder H
    J Nucl Med; 2010 Dec; 51(12):1833-40. PubMed ID: 21078787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of FDG PET/CT and chest CT in the follow-up of lung lesions treated with radiofrequency ablation.
    Deandreis D; Leboulleux S; Dromain C; Auperin A; Coulot J; Lumbroso J; Deschamps F; Rao P; Schlumberger M; de Baère T
    Radiology; 2011 Jan; 258(1):270-6. PubMed ID: 21045185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.
    Casadaban LC; Catalano PJ; Lee LK; Hyun H; Tuncali K; Gerbaudo VH; Shyn PB
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2914-2924. PubMed ID: 33559712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results.
    Okuma T; Okamura T; Matsuoka T; Yamamoto A; Oyama Y; Toyoshima M; Koyama K; Inoue K; Nakamura K; Inoue Y
    Ann Nucl Med; 2006 Feb; 20(2):115-21. PubMed ID: 16615420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.
    Cornelis F; Sotirchos V; Violari E; Sofocleous CT; Schoder H; Durack JC; Siegelbaum RH; Maybody M; Humm J; Solomon SB
    J Nucl Med; 2016 Jul; 57(7):1052-7. PubMed ID: 26912433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.
    Nielsen K; Scheffer HJ; Pieters IC; van Tilborg AA; van Waesberghe JH; Oprea-Lager DE; Meijerink MR; Kazemier G; Hoekstra OS; Schreurs HW; Sietses C; Meijer S; Comans EF; van den Tol PM
    BMC Med Imaging; 2014 Aug; 14():27. PubMed ID: 25103913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
    Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
    Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
    Nascimento C; Borget I; Al Ghuzlan A; Deandreis D; Hartl D; Lumbroso J; Berdelou A; Lepoutre-Lussey C; Mirghani H; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2015 Apr; 25(4):437-44. PubMed ID: 25633259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver tumor F-18 FDG-PET before and immediately after microwave ablation enables imaging and quantification of tumor tissue contraction.
    Yan Z; Khorasani R; Levesque VM; Gerbaudo VH; Shyn PB
    Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1618-1625. PubMed ID: 33175240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG PET and Split-Bolus Multi-Detector Row CT Fusion Imaging in Oncologic Patients: Preliminary Results.
    Scialpi M; Palumbo I; Gravante S; Buresta T; D'Andrea A; Pierotti L; Palumbo B
    Radiology; 2016 Mar; 278(3):873-80. PubMed ID: 26361222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET/CT findings.
    Purandare NC; Rangarajan V; Shah SA; Sharma AR; Kulkarni SS; Kulkarni AV; Dua SG
    Radiographics; 2011; 31(1):201-13. PubMed ID: 21257942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging-guided biopsy of (18)F-FDG-avid extrapulmonary lesions: do lesion location and morphologic features on CT affect the positive predictive value for malignancy?
    Nguyen ML; Gervais DA; Blake MA; Mueller PR; Sahani DV; Hahn PF; Uppot RN
    AJR Am J Roentgenol; 2013 Aug; 201(2):433-8. PubMed ID: 23883226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
    Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin-assisted hydrodissection of the gallbladder fossa during FDG PET/CT-guided liver ablation.
    Tewari SO; Petre EN; Osborne J; Sofocleous CT
    Cardiovasc Intervent Radiol; 2013 Dec; 36(6):1704-1706. PubMed ID: 23839009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography-computed tomography in oncology patients: how often are they malignant?
    Kumar R; Hawkins RA; Yeh BM; Wang ZJ
    Nucl Med Commun; 2011 Sep; 32(9):802-7. PubMed ID: 21685821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.